Diabetes

Retatrutide is among a new class of weight-loss drugs that are being tested for effectiveness

A large epidemiological study of more than 600,000 veterans with diabetes suggests GLP-1 weight-loss medications may reduce drug- and alcohol-related overdoses and deaths

A new trial found that Eli Lilly’s GLP-1 pill resulted in greater reductions in blood sugar levels and weight than oral semaglutide did, but fewer people stayed on it

The recent withdrawal of Hims & Hers’ GLP-1 pill raises questions about the safety and effectiveness of compounded medications

What happens when your body suddenly stops making the one hormone that keeps your blood sugar in check?

The upcoming drugs CagriSema and retatrutide target multiple gut hormones and could cause twice as much weight loss than current treatments. But experts wonder how much is too much

Scientists have successfully transplanted gene-edited insulin-producing cells into a man with type 1 diabetes—allowing him to make some of his own insulin without immunosuppressants.

New WHO guidance calls for a worldwide obesity treatment “ecosystem” to ensure that GLP-1 weight-loss drugs are used fairly

Skipping meals before a big holiday feast probably isn’t the best idea for gut health, experts say. Here’s how to prevent overeating on an empty stomach—and tips for if you do

Top-line results from two large clinical trials by Novo Nordisk, the company behind Ozempic and Wegovy, found oral semaglutide failed to slow down Alzheimer's progression

Studies of insulin, blood sugar and diabetes in other animals such as fish and dogs have already saved millions of lives and could lead to new treatments for type 1 and type 2 diabetes.

People with this autoimmune disease face much shorter life expectancies in lower-income nations.